Coronary assessment before noncardiac surgery current strategies are flawed

Circulation

Volumn 117, Issue 24, 2008, Pages 3145-3151

  Brett, Allan S ^a  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CLOPIDOGREL; DIPYRIDAMOLE; DOBUTAMINE; METOPROLOL; PLACEBO;

ANTICOAGULANT THERAPY; BARE METAL STENT; BETA ADRENERGIC RECEPTOR BLOCKING; CARDIAC PATIENT; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY STENT; DRUG DOSE TITRATION; DRUG EFFICACY; ELECTIVE SURGERY; EXERCISE TEST; FUNCTIONAL STATUS; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HEART SCINTISCANNING; HIGH RISK POPULATION; HUMAN; MEDICAL DECISION MAKING; NON INVASIVE PROCEDURE; PERCUTANEOUS CORONARY INTERVENTION; PHARMACOLOGIC STRESS TESTING; PRACTICE GUIDELINE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REVIEW; RISK MANAGEMENT; STENT THROMBOSIS; STRESS ECHOCARDIOGRAPHY; STROKE; SURGICAL MORTALITY; SURGICAL RISK; THROMBOSIS PREVENTION; TREATMENT OUTCOME; VASCULAR SURGERY; ALGORITHM; CLASSIFICATION; INTRAOPERATIVE PERIOD; MEDICAL SOCIETY; NOTE; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; REPRODUCIBILITY; SURGERY; UNITED STATES;

ALGORITHMS; AMERICAN HOSPITAL ASSOCIATION; HUMANS; INTRAOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PRACTICE GUIDELINES AS TOPIC; PREOPERATIVE CARE; REPRODUCIBILITY OF RESULTS; SURGICAL PROCEDURES, ELECTIVE; SURGICAL PROCEDURES, OPERATIVE; UNITED STATES;

EID: 48249130538     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.107.733154     Document Type: Review

References (41)

1. Kroenke K, Ende J, Hoffman RM, Jackson JL, Lawrence VA, Logio L, O'Malley P, Schapira MM, Zakowski L. Medical Knowledge Self- Assessment Program 14: General Internal Medicine. Philadelphia, Pa: American College of Physicians; 2006:130-132.
2. Schouten O, Bax JJ, Dunkelgrun M, Feringa HH, van Urk H, Poldermans D. Statins for the prevention of perioperative cardiovascular complications in vascular surgery. J Vasc Surg. 2006;44:419-424.
3. Lee TH, Marcantonio ER, Mangione CM, Thomas EJ, Polanczyk CA,Cook EF, Sugarbaker DJ, Donaldson MC, Poss R, Ho KKL, Ludwig LE, Pedan A, Goldman L. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation. 1999;100:1043-1049.
4. Eagle KA, Berger PB, Calkins H, Chaitman BR, Ewy GA, Fleischmann KE, Fleisher LA, Froehlich JB, Gusberg RJ, Leppo JA, Ryan T, Schlant RC, Winters WL. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery: executive summary. JAm Coll Cardiol. 2002;39:542-553.
5. Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof E, Fleischmann KE, Freeman WK, Froelich JB, Kasper EK, Kersten JR, Riegel B, Robb JF. ACC/AHA 2006 guideline update on perioperative cardiovascular evaluation for noncardiac surgery: focused update on perioperative beta- blocker therapy. J Am Coll Cardiol. 2006;47:2343-2355.
6. Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof E, Fleischmann KE, Freeman WK, Froelich JB, Kasper EK, Kersten JR, Riegel B, Robb JF. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: executive summary. Circulation. 2007;116:1971-1996.
7. American College of Cardiology Foundation and American Heart Association: ACC/AHA pocket guideline update: perioperative cardiovascular evaluation for noncardiac surgery. Available at: http://www.acc.org/ qualityandscience/ clinical/guidelines/perio/Periop-pkt.pdf. Accessed March 2, 2008.
8. Kang Y, Lazarus ME. Patient care in internal medicine. In: Green GB, Harris IS, Lin GA, Moylan KC, eds. Washington Manual of Medical Therapeutics. 31st ed. Philadelphia, Pa: Lippincott Williams and Wilkins; 2004:12-14.
9. UpToDate. Available at: http://www.utdol.com. Accessed March 2, 2008.
10. Gibbons RJ, Balady GJ, Bricker JT, Chaitman BR, Fletcher GF, Fro- elicher VF, Mark DB, McCallister BD, Mooss AN, O'Reilly MG, Winters WL, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Hiratzka LF, Jacobs AK, Russell RO, Smith SC. ACC/AHA 2002 guideline update for exercise testing: summary article. Circulation. 2002;106:1883-1892.
11. Klocke FJ, Baird MG, Lorell BH, Bateman TM, Messer JV, Berman DS, O'Gara PT, Carabello BA, Russell RO, Cerqueira MD, St. John Sutton MG, DeMaria AN, Udelson JE, Kennedy JW, Verani MS, Williams KA. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging: executive summary. Circulation. 2003;108:1404-1418.
12. Legner VJ, Doerner D, McCormick WC, Reilly DF. Clinician agreement with perioperative cardiovascular evaluation guidelines and clinical outcomes. Am J Cardiol. 2006;97:118 -122.
13. Boersma E, Poldermans D, Bax JJ, Steyerberg EW, Thomson IR, Banga JD, van de Ven LLM, van Urk H, Roelandt JRTC, for the DECREASE Study Group. Predictors of cardiac events after major vascular surgery: role of clinical characteristics, dobutamine echocardiography, and beta- blocker therapy. JAMA. 2001;285:1865-1873.
14. Fleisher LA, Eagle KA, Shaffer T, Anderson GF. Perioperative- and long-term mortality rates after major vascular surgery: the relationship to preoperative testing in the Medicare population. Anesth Analg. 1999;89:849-855.
15. D'Angelo AJ, Puppala D, Farber A, Murphy AE, Faust GR, Cohen JR. Is preoperative cardiac evaluation for abdominal aortic aneurysm repair necessary? J Vasc Surg. 1997;25:152-156.
16. Massie MT, Rohrer MJ, Leppo JA, Cutler BS. Is coronary angiography necessary for vascular surgery patients who have positive results of dipyridamole thallium scans? J Vasc Surg. 1997;25:975-983.
17. Monahan TS, Shrikhande GV, Pomposelli FB, Skillman JJ, Campbell DR, Scovell SD, Logerfo FW, Hamdan AD. Preoperative cardiac evaluation does not improve or predict perioperative or late survival in asymptomatic diabetic patients undergoing elective infrainguinal arterial reconstruction. J Vasc Surg. 2005;41:38-45.
18. Grayburn PA, Hillis LD. Cardiac events in patients undergoing non- cardiac surgery: shifting the paradigm from noninvasive risk stratification to therapy. Ann Intern Med. 2003;138:506-511.
19. Auerbach A, Goldman L. Assessing and reducing the cardiac risk of noncardiac surgery. Circulation. 2006;113:1361-1376.
20. Poldermans D, Bax JJ, Schouten O, Neskovic AN, Paelinck B, Rocci G, van Dortmont L, Durazzo AES, van de Ven LLM, van Sambeek MRHM, Kertai MD, Boersma E. Should major vascular surgery be delayed because of preoperative testing in intermediate-risk patients receiving beta-blocker therapy with tight heart rate control? J Am Coll Cardiol. 2006;48:964-969.
21. Falcone RA, Nass C, Jermyn R, Hale CM, Stierer T, Jones CE, Walters GK, Fleisher LA. The value of preoperative pharmacologic stress testing before vascular surgery using ACC/AHA guidelines: a prospective, randomized trial. J Cardiothorac Vasc Anesth. 2003;17:694-698.
22. McFalls EO, Ward HB, Moritz TE, Goldman S, Krupski WC, Littooy F, Pierpont G, Santilli S, Rapp J, Hattler B, Shunk K, Jaenicke C, Thottapurathu L, Ellis N, Reda DJ, Henderson WG. Coronary-artery revascularization before elective major vascular surgery. N Engl J Med. 2004;351:2795-2804.
23. Moscucci M, Jones N. Coronary revascularization before noncardiac vascular surgery. J Am Coll Cardiol. 2007;49:1770-1771.
24. Poldermans D, Schouten O, Vidakovic R, Bax JJ, Thomson IR, Hoeks SE, Feringa HHH, Dunkelgrun M, de Jaegere P, Maat A, van Sambeek MRHM, Kertai MD, Boersma E. A clinical randomized trial to evaluate the safety of a noninvasive approach in high-risk patients undergoing major vascular surgery: the DECREASE-V Pilot Study. J Am Coll Cardiol. 2007;49:1763-1769.
25. Wilson SH, Fasseas P, Orford JL, Lennon RJ, Horlocker T, Charnoff NE, Melby S, Berger PB. Clinical outcome of patients undergoing non-cardiac surgery in the two months following coronary stenting. J Am Coll Cardiol. 2003;42:234-240.
26. Kaluza GL, Joseph J, Lee JR, Raizner ME, Raizner AE. Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J Am Coll Cardiol. 2000;35:1288-1294.
27. Pfisterer M, Brunner-La Rocca HP, Buser PT, Rickenbacher P, Hunziker P, Mueller C, Jeder R, Bader F, Osswald S, Kaiser C. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol. 2006;48:2584-2591.
28. Eisenstein EL, Anstrom KJ, Kong DF, Shaw LK, Tuttle RH, Mark DB, Kramer JM, Harrington RA, Matchar DB, Kandzari DE, Peterson ED, Schulman KA, Califf RM. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JaAMA. 2007;297:159-168.
29. Grines CL, Bonow RO, Casey DE, Gardner TJ, Lockhart PB, Moliterno DJ, O'Gara P, Whitlow P. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. Circulation. 2007;115:813-818.
30. Boden WE, O'Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, Knudtson M, Dada Marcin, Casperson P, Harris CL, Chaitman BR, Shaw L, Gosselin G, Nawaz S, Title LM, Gau G, Blaustein AS, BoothDC, Bates ER, Spertus JA, Berman DS, Mancini J, Weintraub WS, for the COURAGE Trial Research Group. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356:1503-1516.
31. Katritis DG, Ioannidis JPA. Percutaneous coronary intervention versus conservative therapy in nonacute coronary artery disease: a meta-analysis. Circulation. 2005;111:2906-2912.
32. Mangano DT, Layug EL, Wallace A, Tateo I; Multicenter Study of Perioperative Ischemia Research Group. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. N Engl J Med. 1996;335:1713-1720.
33. Poldermans D, Boersma E, Bax JJ, Thomson IR, van de Ven LLM, Blankensteijn JD, Baars HF, Yo T, Trocino G, Vigna C, Roelandt JRTC, van Urk H, Fioretti PM, Paelinck B. The effect of bisoprolol on periop- erative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. N Engl J Med. 1999;341:1789-1794.
34. Devereux PJ, Yusuf S, Yang H, Choi P T-L, Guyatt GH. Are the recommendations to use perioperative beta-blocker therapy in patients undergoing noncardiac surgery based on reliable evidence? CMAJ. 2004; 71:245-247.
35. McCullough PA. Failure of beta-blockers in the reduction of periopera- tive events: where did we go wrong? Am Heart J. 2006;152:815-818.
36. Juul AB, Wetterslev J, Gluud C, Kofoed-Enevoldsen A, Jensen G, Callesen T, Norgaard P, Fruergaard P, Bestle M, Vedelsdal R, Miran A, Jacobsen J, Roed J, Mortensen M, Jorgensen L, Jorgensen J, Rovsing M, Petersen PL, Pott F, Haas M, Albret R, Nielsen LL, Johansson G, Stjernholm P, Molgaard Y, Foss NB, Elkjaer J, Dehlie B, Boysen K, Zaric D, Munksgaard A, Madsen JB, Oberg B, Khanykin B, Blemmer T, Yndgaard S, Perko G, Wang LP, Winkel P, Hilden J, Jensen P, Salas N. Effect of perioperative beta blockade in patients with diabetes undergoing major non-cardiac surgery: randomised placebo-controlled blinded mul- ticentre trial. BMJ. 2006;332:1482-1485.
37. Yang H, Raymer K, Butler R, Parlow J, Roberts R. The effects of perioperative beta-blockade: results of the Metoprolol after Vascular Surgery (MaVS) study, a randomized controlled trial. Am Heart J. 2006; 52:983-990.
38. The POISE Trial Investigators. Rationale, design, and organization of the PeriOperative Ischemic Evaluation (POISE) trial: a randomized controlled trial of metoprolol versus placebo in patients undergoing non- cardiac surgery. Am Heart J. 2006;152:223-230.
39. POISE Study Group. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised ontrolled trial. Lancet. 2008;371:1839-1847.
40. NelsonCL, HerndonJE, MarkDB, PryorDB, CaliffRM, HlatkyMA. Relation f clinical and angiographic factors to functional capacity as measured by the uke Activity Status Index. Am JCardiol. 1991;68:973-975.
41. Hindler K, Shaw D, Samuels J, Fulton S, Collard CD, Riedel B. mproved postoperative outcomes associated with preoperative statin therapy. Anesthesiology. 2006;105:1260 -1272.